Musculoskeletal Disease Center, Jerry L. Pettis VA Medical Center, Loma Linda, CA 92357, USA
Mol Cell Biol. 2010 Feb;30(3):711-21. doi: 10.1128/MCB.00610-09. Epub 2009 Dec 7.
Mutations of ephrin B1 in humans result in craniofrontonasal syndrome. Because little is known of the role and mechanism of action of ephrin B1 in bone, we examined the function of osteoblast-produced ephrin B1 in vivo and identified the molecular mechanism by which ephrin B1 reverse signaling regulates bone formation. Targeted deletion of the ephrin B1 gene in type 1alpha2 collagen-producing cells resulted in severe calvarial defects, decreased bone size, bone mineral density, and trabecular bone volume, caused by impairment in osterix expression and osteoblast differentiation. Coimmunoprecipitation of the TAZ complex with TAZ-specific antibody revealed a protein complex containing ephrin B1, PTPN13, NHERF1, and TAZ in bone marrow stromal (BMS) cells. Activation of ephrin B1 reverse signaling with soluble EphB2-Fc led to a time-dependent increase in TAZ dephosphorylation and shuttling from cytoplasm to nucleus. Treatment of BMS cells with exogenous EphB2-Fc resulted in a 4-fold increase in osterix expression as determined by Western blotting. Disruption of TAZ expression using specific lentivirus small hairpin RNA (shRNA) decreased TAZ mRNA by 80% and ephrin B1 reverse signaling-mediated increases in osterix mRNA by 75%. Knockdown of NHERF1 expression reduced basal levels of osterix expression by 90% and abolished ephrin B1-mediated induction of osterix expression. We conclude that locally produced ephrin B1 mediates its effects on osteoblast differentiation by a novel molecular mechanism in which activation of reverse signaling leads to dephosphorylation of TAZ and subsequent release of TAZ from the ephrin B1/NHERF1/TAZ complex to translocate to the nucleus to induce expression of the osterix gene and perhaps other osteoblast differentiation genes. Our findings provide strong evidence that ephrin B1 reverse signaling in osteoblasts is critical for BMS cell differentiation and bone formation.
人类 Ephrin B1 突变导致颅面前颅缝发育不全综合征。由于 Ephrin B1 在骨骼中的作用和作用机制知之甚少,我们在体内研究了成骨细胞产生的 Ephrin B1 的功能,并确定了 Ephrin B1 反向信号转导调节骨形成的分子机制。在 1 型α2 胶原产生细胞中 Ephrin B1 基因的靶向缺失导致严重的颅顶缺陷,骨大小、骨密度和小梁骨体积减少,这是由于 osterix 表达和成骨细胞分化受损所致。用 TAZ 特异性抗体进行共免疫沉淀显示,在骨髓基质(BMS)细胞中存在包含 Ephrin B1、PTPN13、NHERF1 和 TAZ 的蛋白质复合物。用可溶性 EphB2-Fc 激活 Ephrin B1 反向信号转导导致 TAZ 去磷酸化和从细胞质向核内易位的时间依赖性增加。用外源性 EphB2-Fc 处理 BMS 细胞导致 Western 印迹分析中 osterix 表达增加 4 倍。用特异性慢病毒小发夹 RNA(shRNA)敲低 TAZ 表达使 TAZ mRNA 减少 80%,并使 Ephrin B1 反向信号介导的 osterix mRNA 增加减少 75%。NHERF1 表达的破坏使 osterix 表达的基础水平降低 90%,并消除了 Ephrin B1 介导的 osterix 表达诱导。我们得出结论,局部产生的 Ephrin B1 通过一种新的分子机制对成骨细胞分化产生影响,其中反向信号的激活导致 TAZ 的去磷酸化,随后 TAZ 从 Ephrin B1/NHERF1/TAZ 复合物中释放出来,易位到核内,诱导 osterix 基因的表达,也许还有其他成骨细胞分化基因的表达。我们的研究结果提供了强有力的证据,证明成骨细胞中的 Ephrin B1 反向信号转导对于 BMS 细胞分化和骨形成至关重要。